Latest Headlines

1. Coronavirus SARS-CoV-2 IgG Antibody Under FDA’s Emergency Use Authorization 5/20/2020

   Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that it is currently offering a SARS-CoV-2 IgG ELISA assay kit for serological detection of IgG antibodies against the novel coronavirus under the FDA’s Emergency Use Authorization (EUA) authority as both products and services

2. New UV-C Disinfection Product UV-Cube Offers Quick And Easy Way To Disinfect Handheld Equipment And Devices, Eliminates 99.9% Of Infection-Causing Pathogens After One Minute 5/20/2020

   Proximity Systems, Inc., a leading provider in innovative health care furniture and technology, announced UV-Cube, a new product in their lineup of UV-C disinfection devices

3. Myriad Receives FDA Approval Of BRACAnalysis CDx® As A Companion Diagnostic For Lynparza® In HRR-Mutated Metastatic Castration-Resistant Prostate Cancer 5/20/2020

   Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) approved the BRACAnalysis CDx®  test for use as a companion diagnostic by healthcare professionals to identify men with metastatic castration-resistant prostate cancer (mCRPC) who are eligible for treatment with Lynparza® (olaparib)

4. Altogen Labs Preclinical Efficacy And In Vivo Toxicology Services 5/19/2020

   Altogen Labs, a GLP-compliant contract research laboratory (CRO), offers in vivo xenograft efficacy studies and pharmacology/toxicology services designed to accelerate preclinical research and drug development

5. Medical Diagnostic Laboratories, L.L.C., Expands Availability Of Coronavirus Disease 2019 (COVID-19) Testing Into New York And Increases Testing Capabilities 5/19/2020

   Medical Diagnostic Laboratories, L.L.C., (MDL), a Genesis Biotechnology Group® (GBG) member company and CLIA-certified, CAP-accredited laboratory specializing in high-complexity, state-of-the-art, automated DNA-based molecular analyses, expanded availability of its molecular test for SARS-CoV-2 (COVID-19) into New York state after receiving approval from the Wadsworth Center, New York State Department of Health

6. Chip Kits For High Throughput Antibody Validation 5/19/2020

   Porvair Sciences report how its Chromatrap ChIP kits provide an outstanding solution for antibodies suppliers looking to validate the performance of the antibodies they produce for chromatin immunoprecipitation (ChIP) assay kits

7. CCD Image Sensor Technology Plays Key Role In COVID-19 Diagnostics 5/19/2020

   Teledyne is supplying high performance charged coupled devices (CCDs) for COVID-19 diagnostic scientific instruments

8.  20/20 GeneSystems To Provide Newly FDA Authorized COVID-19 Antibody Blood Test 5/18/2020

   20/20 GeneSystems, Inc. announced today that it will offer in its CLIA laboratory a COVID-19 antibody test that received an Emergency Use Authorization (EUA) from the FDA on May 3. 

9. Gold Standard Diagnostics Multiplex Real-Time PCR Assay For SARS-CoV-2 Pathogen Detection Now Available In The US 5/18/2020

   Gold Standard Diagnostics Inc. today announced the EUA submission of a Multiplex Real-Time, reverse-transcriptase polymerase chain reaction (RT-PCR) assay for the direct qualitative pathogen detection of the novel coronavirus (SARS-CoV-2)

10. Advanced Biological Laboratories Receives CE-IVD Registration For Its SANGER And For Its NGS DeepChek®-HIV Genotyping Drug Resistance Assays 5/18/2020

    Advanced Biological Laboratories (ABL) announced today the CE-IVD marking of its DeepChek®-HIV assays, is now available for in-vitro diagnostics. Intended to be used on HIV-1 Group M viruses from patients diagnosed with HIV infection, the assays deliver standardized, open and flexible solution suited to clinical settings performing sequencing through Capillary Electrophoresis and Next Generation Sequencing (NGS) systems